Although its expression is positively associated with NPM1 and FLT3 mutations in AML, the link is not absolute; for example, more than a third of NPM1 mutant cases do not express IRX3 (Wouters et al., 2009). This evidence concerns the gene NPM1 and acute myeloid leukemia.